The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review
dc.contributor.author | Cash, Brooks D. | en_US |
dc.contributor.author | Schoenfeld, Philip S. | en_US |
dc.contributor.author | Chey, William D. | en_US |
dc.date.accessioned | 2010-06-01T19:22:05Z | |
dc.date.available | 2010-06-01T19:22:05Z | |
dc.date.issued | 2002-11 | en_US |
dc.identifier.citation | Cash, Brooks D . ; Schoenfeld, Philip; Chey, William D . (2002). "The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review." The American Journal of Gastroenterology 97(11): 2812-2819. <http://hdl.handle.net/2027.42/72511> | en_US |
dc.identifier.issn | 0002-9270 | en_US |
dc.identifier.issn | 1572-0241 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72511 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12425553&dopt=citation | en_US |
dc.description.abstract | The aim of this study was to determine the pretest probability of organic GI disease and the accuracy of diagnostic tests for organic GI disease in patients who meet symptom-based criteria for irritable bowel syndrome (IBS). METHODS : After a comprehensive literature search for studies examining the accuracy of diagnostic tests for organic GI disease among patients who meet symptom-based criteria for IBS, two independent observers qualitatively assessed the methodology of selected studies and extracted data. Data on the pretest probability of organic GI disease in this population and the accuracy of currently recommended diagnostic tests were converted to descriptive tables. RESULTS : Among patients meeting symptom-based criteria for IBS, the pretest probability of inflammatory bowel disease, colorectal cancer, or infectious diarrhea is less than 1%. Currently recommended diagnostic tests rarely identify organic GI disease in patients fulfilling symptom-based criteria for IBS. However, the pretest probability of celiac disease in patients meeting symptom-based criteria for IBS was 10 times higher than the prevalence of celiac disease in the general population. CONCLUSION : There is insufficient evidence to recommend the routine performance of a standardized battery of diagnostic tests in patients who meet symptom-based criteria for IBS. Based upon the increased pretest probability of celiac disease, routine performance of serological tests for celiac disease may be useful in this patient population, though additional study is needed in this area. | en_US |
dc.format.extent | 66304 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2002 by Am. Coll. of Gastroenterology | en_US |
dc.title | The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Gastroenterology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | VA Center for Excellence in Health Care Research, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Division of Gastroenterology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA | en_US |
dc.identifier.pmid | 12425553 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72511/1/j.1572-0241.2002.07027.x.pdf | |
dc.identifier.doi | 10.1111/j.1572-0241.2002.07027.x | en_US |
dc.identifier.source | The American Journal of Gastroenterology | en_US |
dc.identifier.citedreference | Drossman D.A., Whitehead W.E., Camilleri M.. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112: 2120 – 2137. | en_US |
dc.identifier.citedreference | Sandler R.S.. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409 – 415. | en_US |
dc.identifier.citedreference | Talley N.J., Gabriel S.E., Harmsen W.S., et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736 – 1741. | en_US |
dc.identifier.citedreference | Goodman C., Cronin K., Gemmen E., et al The burden of gastrointestinal diseases. Bethesda, MD: American Gastroenterological Association, 2001: 2 – 65. | en_US |
dc.identifier.citedreference | Manning A.P., Thompson W.G., Heaton K.W., et al. Towards a positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 653 – 654. | en_US |
dc.identifier.citedreference | Thompson W.G., Dotewall G., Drossman D.A., et al. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92 – 95. | en_US |
dc.identifier.citedreference | Thompson W.G., Longstreth G.F., Drossman D.A., et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 ( suppl II ): II43 – II47. | en_US |
dc.identifier.citedreference | Vanner S.J., Depew W.T., Paterson W.G., et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastrenterol 1999; 94: 2803 – 2807. | en_US |
dc.identifier.citedreference | Saito Y.A., Locke G.R., Talley N.J., et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2679 – 2681. | en_US |
dc.identifier.citedreference | Thompson W.G., Irvine E.J., Pare P., et al. Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225 – 235. | en_US |
dc.identifier.citedreference | Mearin F., Badia X., Balboa A., et al. Irritable bowel syndrome prevalence varies enormously depending upon the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1121 – 1122. | en_US |
dc.identifier.citedreference | Chey W.D., Olden K., Carter E.. Utility of the Rome I and Rome II criteria for IBS in US women. Am J Gastroenterol. 2002 ( in press ). | en_US |
dc.identifier.citedreference | Drossman D.A.. An integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999; 13 ( suppl 2 ): 3 – 14. | en_US |
dc.identifier.citedreference | Camilleri M., Prather C.M.. The irritable bowel syndrome: Mechanisms and a practical approach to management. Ann Intern Med 1992; 116: 1001 – 1008. | en_US |
dc.identifier.citedreference | 15. American Gastroenterological Association Medical Position Statement Irritable bowel syndrome. Gastroenterology 1997; 112: 2118 – 2119. | en_US |
dc.identifier.citedreference | Schmulson M.W., Chang L.. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107: 20S – 26S. | en_US |
dc.identifier.citedreference | Camilleri M.. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652 – 668. | en_US |
dc.identifier.citedreference | Schoenfeld P.S., Guyatt G., Hamilton F., et al. An evidence-based approach to gastroenterology diagnosis. Gastroenterology 1999; 116: 1230 – 1237. | en_US |
dc.identifier.citedreference | Jaeschke R., Guyatt G.H., Sackett D.L.. Users guide to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence based medicine working group. JAMA 1994; 271: 389 – 391. | en_US |
dc.identifier.citedreference | Hasler W.L., Owyang C.. Irritable bowel syndrome. In: Yamada T., ed. Textbook of gastroenterology. Philadelphia: JB Lippincott, 1991: 1696 – 1716. | en_US |
dc.identifier.citedreference | Lijmer J.G., Mol B.W., Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061 – 1066. | en_US |
dc.identifier.citedreference | Irwig L., Tostetson A.N., Gastonis C., et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994; 120: 667 – 676. | en_US |
dc.identifier.citedreference | Hamm L.R., Sorrells S.C., Harding J.P., et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94: 1279 – 1282. | en_US |
dc.identifier.citedreference | Tolliver B.A., Herrera J.L., DiPalma J.A.. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994; 89: 176 – 178. | en_US |
dc.identifier.citedreference | MacIntosh D.G., Thompson W.G., Patel D.G., et al. Is rectal biopsy necessary in irritable bowel syndrome?. Am J Gastroenterol 1992; 87: 1407 – 1409. | en_US |
dc.identifier.citedreference | Francis C.Y., Duffy J.N., Whorwell P.J., et al. Does routine ultrasound enhance diagnostic accuracy in irritable bowel syndrome?. Am J Gastroenterol 1996; 91: 1348 – 1350. | en_US |
dc.identifier.citedreference | Sanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001; 358: 1504 – 1508. | en_US |
dc.identifier.citedreference | Pimentel M., Chow E.J., Lin H.C.. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503 – 3506. | en_US |
dc.identifier.citedreference | Helfand M., Redfern C.C.. Screening for thyroid disease: An update. Ann Intern Med 1998; 129: 144 – 158. | en_US |
dc.identifier.citedreference | Scrimshaw N.S., Murray E.B.. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48 ( suppl 4 ): 1079 – 1159. | en_US |
dc.identifier.citedreference | Bourlioux P., Pochart P.. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988; 56: 217 – 258. | en_US |
dc.identifier.citedreference | Tolliver B.A., Jackson M.S., Jackson K.L., et al. Does lactose maldigestion really play a role in the irritable bowel syndrome?. J Clin Gastroenterol 1996; 23: 15 – 17. | en_US |
dc.identifier.citedreference | Otte J.J., Larsen L., Andersen J.R.. Irritable bowel syndrome and symptomatic diverticular disease—Different diseases. Am J Gastroenterol 1986; 81: 529 – 531. | en_US |
dc.identifier.citedreference | Ciclitira P.J.. AGA technical review on celiac sprue. Gastroenterology 2001; 120: 1526 – 1540. | en_US |
dc.identifier.citedreference | Wahnschaffe U., Ullrich R., Riecken E.O., et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001; 121: 1329 – 1338. | en_US |
dc.identifier.citedreference | Rostami K., Kerckhaert J., Tiemessen R., et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888 – 894. | en_US |
dc.identifier.citedreference | Tursi A., Brandimarte G., Giorgetti G., et al. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 2001; 96: 1507 – 1510. | en_US |
dc.identifier.citedreference | Hawkey C.J.. Irritable bowel syndrome clinical trial design: Future needs. Am J Med 1999; 107: 98S – 102S. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.